High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma

por Zhang, Yi-An, Zhu, Ji-Min, Yin, Jie, Tang, Wen-Qing, Guo, Yan-Mei, Shen, Xi-Zhong, Liu, Tao-Tao
Publicado 2014

lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation

por Lin, Xia-Hui, Zhang, Dan-Ying, Liu, Zhi-Yong, Tang, Wen-qing, Chen, Rong-Xin, Li, Dong-ping, Weng, Shuqiang, Dong, Ling
Publicado 2022

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation

por Lin, Xia-Hui, Li, Dong-ping, Liu, Zhi-Yong, Zhang, Si, Tang, Wen-qing, Chen, Rong-xin, Weng, Shu-qiang, Tseng, Yu-jen, Xue, Ru-yi, Dong, Ling
Publicado 2023

circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma

por Lin, Xia-Hui, Liu, Zhi-Yong, Zhang, Dan-Ying, Zhang, Si, Tang, Wen-Qing, Li, Dong-Ping, Zhang, Feng, Chen, Rong-Xin, Weng, Shu-Qiang, Xue, Ru-Yi, Dong, Ling
Publicado 2022